2024-11-0920210954-691X10.1097/MEG.00000000000018842-s2.0-85099171986http://dx.doi.org/10.1097/MEG.0000000000001884https://hdl.handle.net/20.500.14288/15078Objectives Alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) are used as tumour markers for the diagnosis of hepatocellular carcinoma (HCC). We investigate whether combined liver function marker such as gamma-glutamyl transferase (GGT) and aspartate aminotransferase (AST) with alpha-fetoprotein (AFP) and PIVKA-II increase their diagnostic predictive value in diagnosis of HCC.GastroenterologyHepatologyPredictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidatesJournal Article1473-5687756971300023Q410965